when

Latest
Archive

by source

All Sources
Sources Page

department

Clinical
Regulatory
Medical Affairs
Commercial
R&D / Discovery
Biostatistics / Data
Manufacturing / CMC
Market Access

therapeutic area

Oncology
Immunology
Neuroscience
Cardiovascular
Metabolic
Rare Disease
Infectious Disease

location & type

Remote Only
US Only
California
Massachusetts
Internships
Phase 3 Roles
All Jobs →

Sign In Subscribe

pharmadog

fetch the data · sniff the signal

Discover

Jobs
News

Hubs

Topics
Patent cliff
Publications

Tools

Compare
Search
Bookmarks

Trust

About
Sources
Contact

Legal

Privacy
Terms
Pricing

© 2026 pharmadog.xyz

made by humans and a good dog

home
jobs
news
search

PATH · news · pharmadog

← back to PATH

News mentioning PATH

184 stories

May 29, 26Replimune takes third swing at cancer drug approval following ‘productive’ FDA talksbiopharma dive

May 29, 26AstraZeneca seeks path for failed antibody; Imfinzi, Tremfya get label expansionsendpoints

May 19, 26How AI helped treat a newborn’s ultra rare disease. ‘It was almost like a light switch.’stat

May 19, 26STAT+: At a time of tumult at FDA, a former commissioner is hopeful it’s on a better pathstat

May 19, 26BioMarin drug acquired in buyout misses goal in rare disease studybiopharma dive

May 16, 26Opinion: The cloudy truth about ‘blue zones’stat

May 15, 26FDA hold puts Aardvark Prader-Willi drug in limbobiopharma dive

May 15, 26India’s pharma industry is going global. But can it catch up to China?biopharma dive

May 14, 26With new data, Regenxbio to seek FDA approval of Duchenne gene therapybiopharma dive

May 14, 26STAT+: Treatment for alcohol addiction is undergoing a seismic shift. Many say it’s overduestat

May 13, 26Opinion: The hantavirus is a wake-up call. Will the Trump administration answer it?stat

May 13, 26STAT+: AI medical devices’ dirty FDA secretstat

May 13, 26How Reimagined Research Endeavors Intersect With Dignified End-of-Life Care: With D. Ross Camidge, MD, PhD; and Charles D. Blanke, MD, FACP, FASCOonclive

May 12, 26Dr McCann on the FDA Approval of Vepdegestrant for ESR1-Mutated, ER+ Advanced Breast Canceronclive

May 12, 26Temple Health’s Fox Chase Cancer Center and Labcorp Collaborate to Test Ultra-Sensitive Blood-Based Assay for Early-Stage Lung Cancer Recurrence Riskonclive

May 11, 26Precision in motion: Decoding the critical operations behind the logistics of next-generation cell and gene therapiesbiopharma dive

May 11, 26Opinion: AI doctors should be licensed. Here’s a framework to do thatstat

May 9, 26Opinion: Dr. Glaucomflecken wants the corporatization of medicine to be national newsstat

May 8, 26FDA to reevaluate spurned cell therapy; Under-the-skin Leqembi review extendedbiopharma dive

May 8, 26The aging scientific workforce collides with rising fabricating citations in medical journalsstat

May 7, 26Hospital shootings steadily increased since 2000stat

May 6, 26STAT+: How a global effort to explore the ‘dark proteome’ is upending our understanding of human diseasestat

May 6, 26STAT+: When the path to good AI is littered with bad datastat

May 1, 26Summit’s ‘self-inflicted’ stumble; Esperion’s take-private dealbiopharma dive

Apr 30, 26UniQure, in ‘symbolic’ win, to seek UK approval of Huntington’s gene therapybiopharma dive

Apr 30, 26Opinion: Are international medical graduates taking residency spots from Americans? We did the mathstat

Apr 30, 26Securing NIH awards is getting more competitive — and confusingstat

Apr 29, 26STAT+: Supreme Court justices appear to signal ‘skinny labeling’ can survivestat

Apr 28, 26STAT+: Google clinical director says AI can be a ‘bridge’ for people having a mental health crisisstat

Apr 24, 26Sanofi MS drug rejected in US gets an endorsement in Europebiopharma dive

← prevpage 6 of 7next →